Nogimori T, Emerson C H, Braverman L E, Wu C F, Gambino J, Wright G E
J Med Chem. 1985 Nov;28(11):1692-4. doi: 10.1021/jm00149a026.
Several 6-anilino-2-thiouracils were synthesized and tested for their ability to inhibit the inner-ring iodothyronine deiodinase from human placenta. The p-ethyl and p-n-butyl analogues were strongly inhibitory to the enzyme and were much more effective than the standard deiodinase inhibitor, 6-propyl-2-thiouracil. The degree of inhibition caused by 6-(p-n-butylanilino)-2-thiouracil was, moreover, unaffected by high concentrations of reducing agent in the enzyme assay. Attempts to prepare 3-alkyl derivatives via S-debenzylation of 2-benzylthio intermediates led to rearrangement to, for example, 3-methyl-5-benzyl-6-amino-2-thiouracil. This compound also strongly inhibited the deiodinase reaction. Preliminary results suggest that these compounds are useful to study in vitro and in vivo metabolism of thyroid hormones and may be clinically useful to enhance the availability of active thyroid hormones to certain organs.
合成了几种6-苯胺基-2-硫脲嘧啶,并测试了它们抑制人胎盘内环甲状腺原氨酸脱碘酶的能力。对乙基和对正丁基类似物对该酶具有强烈抑制作用,且比标准脱碘酶抑制剂6-丙基-2-硫脲嘧啶更有效。此外,在酶分析中,6-(对正丁基苯胺基)-2-硫脲嘧啶引起的抑制程度不受高浓度还原剂的影响。试图通过2-苄硫基中间体的S-脱苄基制备3-烷基衍生物,导致重排为例如3-甲基-5-苄基-6-氨基-2-硫脲嘧啶。该化合物也强烈抑制脱碘酶反应。初步结果表明,这些化合物对于研究甲状腺激素的体外和体内代谢有用,并且在临床上可能有助于提高某些器官中活性甲状腺激素的可用性。